{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T02:21:34Z","timestamp":1649038894364},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"published-print":{"date-parts":[[1998,6]]},"DOI":"10.1007\/bf03339660","type":"journal-article","created":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T21:27:52Z","timestamp":1389907672000},"page":"263-268","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacological management of osteoporosis"],"prefix":"10.1007","volume":"10","author":[{"given":"S. E.","family":"Papapoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,28]]},"reference":[{"key":"BF03339660_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-117-1-1","volume":"117","author":"EG Lufkin","year":"1992","unstructured":"Lufkin E.G., Wahner H.W., O\u2019Fallon W.M., Hodgson S.F., Kotowicz M.A., Lane A.W., Judd H.L., Caplan R.H., Riggs B.L.: Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann. Intern. Med. 117: 1\u20139, 1992.","journal-title":"Ann. Intern. Med."},{"key":"BF03339660_CR2","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM199005033221803","volume":"322","author":"T Storm","year":"1990","unstructured":"Storm T., Thamsborg G., Steinicke T., Genant H.K., Sorensen O.H.: Effect of intermittent cyclic etidronate therapy on bone mass and fracture rate in women with postmenopau-sal osteoporosis. N. Engl. J. Med. 322: 1265\u20131271, 1990.","journal-title":"N. Engl. J. Med."},{"key":"BF03339660_CR3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","volume":"323","author":"NB Watts","year":"1990","unstructured":"Watts N.B., Harris S.T., Genant H.K., Wasnich R.D., Miller P.D., Jackson R.D., Licata A.A., Ross P., Woodson G.C., Yanover M.J., Mysiw W.J., Kohse L., Rao M.B., Steiger P., Richmond B., Chesnut C.H. III: Intermittent cyclic etidronate treatment of postmenopausal osteoporosis. N. Engl. J. Med. 323: 73\u201379, 1990.","journal-title":"N. Engl. J. Med."},{"key":"BF03339660_CR4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9343(93)90350-X","volume":"95","author":"ST Harris","year":"1993","unstructured":"Harris S.T., Watts N.B., Jackson R.D., Genant H.K., Wasnich R.D., Ross P., Miller P.D., Licata A.A., Chesnut C.H. III: Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am. J. Med. 95: 557\u2013567, 1993.","journal-title":"Am. J. Med."},{"key":"BF03339660_CR5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/rheumatology\/37.1.87","volume":"37","author":"TP Staa van","year":"1998","unstructured":"van Staa T.P., Abenhaim L., Cooper C.: Use of cyclical etid-ronate and prevention of non-vertebral fractures. b r. J. Rheumatol. 37: 87\u201394, 1998.","journal-title":"b r. J. Rheumatol."},{"key":"BF03339660_CR6","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","volume":"333","author":"UA Liberman","year":"1995","unstructured":"Liberman U.A., Weiss S.R., Br\u00f6ll J., Minne H.W., Qhan H., Bell N.H., Rodriguez-Portales J., Downs R.W. Jr, Dequeker J., Favus M., Seeman E., Recker R.R., Capizzi T., Santora A.C., Lombardi A., Shah R.V., Hirsch L.J., Karpf D.V.: Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N. Engl. J. Med. 333: 1437\u20131443, 1995.","journal-title":"N. Engl. J. Med."},{"key":"BF03339660_CR7","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jama.1997.03540380073035","volume":"227","author":"DB Karpf","year":"1997","unstructured":"Karpf D.B., Shapiro D.R., Seeman E., Ensrud K.E., Johnston C.C., Adami S., Harris S.T., Santora A.C., Hirsch L.J., Oppenheimer L., Thompson D.: Prevention of non-vertebral fractures by alendronate: a meta-analysis. JAMA 227: 1159\u20131164, 1997.","journal-title":"JAMA"},{"key":"BF03339660_CR8","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","volume":"348","author":"DM Black","year":"1996","unstructured":"Black D.M., Cummings S.R., Karpf D.B., Cauley J.A., Thompson D.E., Nevitt M.C., Bauer D.C., Genant H.K., Haskell W.L., Marcus R., Ott S.M., Torner J.C., Quandt S.A., Reiss T.F., Ensrud K.E.: Randomized trial of effect of alendronate on risk of fractures in women with existing vertebral fractures. Lancet 348: 1535\u20131541, 1996.","journal-title":"Lancet"},{"key":"BF03339660_CR9","first-page":"968","volume":"78","author":"SM Ott","year":"1994","unstructured":"Ott S.M., Woodson G.C., Huffer W.E., Miller P.D., Watts N.B.: Bone histomorphometric changes after cyclic therapy with phosphate and etidronate sodium in women with post-menopausal osteoporosis. J. Clin. Endocrinol. Metab. 78: 968\u2013972, 1994.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03339660_CR10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jbmr.5650080211","volume":"8","author":"T Storm","year":"1993","unstructured":"Storm T., Steinicke T., Thamsborg G., Melsen F.: Changes in bone histomorphometry after long-term treatment with intermittent cyclic etidronate for postmenopausal osteoporosis. J. bone Miner. Res. 8: 199\u2013208, 1993.","journal-title":"J. bone Miner. Res."},{"key":"BF03339660_CR11","first-page":"2183","volume":"22","author":"T Thomas","year":"1995","unstructured":"Thomas T., Lafage M.H., Alexandre C.: Atypical osteomalacia after 2-year etidronate intermittent cyclic administration in osteoporosis. J. Rheumatol. 22: 2183\u20132185, 1995.","journal-title":"J. Rheumatol."},{"key":"BF03339660_CR12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0002-9343(99)80102-8","volume":"99","author":"SJ Wimalawansa","year":"1995","unstructured":"Wimalawansa S.J.: Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and the vertebrae: four-year randomized study. Am. J. Med. 99: 36\u201342, 1995.","journal-title":"Am. J. Med."},{"key":"BF03339660_CR13","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJM199610033351403","volume":"335","author":"PC Groen De","year":"1996","unstructured":"De Groen P.C., Lubbe D.F., Hirsch L.J., Daifotis A., Stephenson W., Freedholm D., Pryor-Tillotson S., Seleznick M.J., Pinkas H., Wang K.K.: Esophagitis associated with the use of alendronate. N. Engl. J. Med. 335: 1016\u20131021, 1996.","journal-title":"N. Engl. J. Med."},{"key":"BF03339660_CR14","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/bmj.305.6862.1124","volume":"305","author":"JA Kanis","year":"1992","unstructured":"Kanis J.A., Johnell O., Gullberg B., Allander E., Dilsen G., Gennari C., Lopez Vaz A.A., Lyritis G.P., Mazzuoli G., Miravet L., Passeri M., Perez Cano R., Rapado A., Ribot C.: Evidence for the efficacy of bone active drugs in the prevention of hip fractures. b r. Med. J. 305: 1124\u20131128, 1992.","journal-title":"b r. Med. J."},{"key":"BF03339660_CR15","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/jbmr.5650111218","volume":"11","author":"RR Recker","year":"1996","unstructured":"Recker R.R., Hinders S., Davies K.M., Heaney R.P., Stegman M.R., Lappe J.M., Kimmel D.B.: Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J. bone Miner. Res. 11: 1961\u20131966, 1996.","journal-title":"J. bone Miner. Res."},{"key":"BF03339660_CR16","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/bmj.308.6936.1081","volume":"308","author":"MC Chapuy","year":"1994","unstructured":"Chapuy M.C., Arlot M.E., Delmas P.D., Meunier P.J.: Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. b r. Med. J. 308: 1081\u20131082, 1994.","journal-title":"b r. Med. J."},{"key":"BF03339660_CR17","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJM199212033272305","volume":"327","author":"MC Chapuy","year":"1992","unstructured":"Chapuy M.C., Arlot M.E., Duboef F., Brun J., Crouzet B., Arnaud S., Delmas P.D., Meunier P.J.: Vitamin D3 and calcium to prevent hip fractures in elderly women. N. Engl. J. Med. 327: 1637\u20131642, 1992.","journal-title":"N. Engl. J. Med."},{"key":"BF03339660_CR18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/bmj.305.6853.556","volume":"305","author":"K Overgaard","year":"1992","unstructured":"Overgaard K., Hansen M.A., Jensen S.B., Christiansen C.: Effect of calcitonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. br. Med. J. 305: 556\u2013561, 1992.","journal-title":"br. Med. J."},{"key":"BF03339660_CR19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.7326\/0003-4819-110-4-267","volume":"110","author":"S Ott","year":"1989","unstructured":"Ott S., Chesnut C.H. III: Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann. Intern. Med. 110: 267\u2013274, 1989.","journal-title":"Ann. Intern. Med."},{"issue":"Suppl.1","key":"BF03339660_CR20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0026-0495(90)90269-I","volume":"4","author":"JC Gallagher","year":"1990","unstructured":"Gallagher J.C., Riggs B.L.: Action of 1,25-dihydroxyvitamin D3 on calcium balance and bone turnover and its effects on vertebral fracture rate. Metabolism 4 (Suppl. 1): 30\u201334, 1990.","journal-title":"Metabolism"},{"key":"BF03339660_CR21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199202063260601","volume":"326","author":"MW Tilyard","year":"1992","unstructured":"Tilyard M.W., Spears G.F.S., Thomson J., Dovey S.: Treatment of postmenopausal osteoporosis with calcitriol or calcium. N. Engl. J. Med. 326: 357\u2013362, 1992.","journal-title":"N. Engl. J. Med."},{"key":"BF03339660_CR22","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1056\/NEJM199003223221203","volume":"322","author":"BL Riggs","year":"1990","unstructured":"Riggs B.L., Hodgson S.F., O\u2019Fallon W.M., Chao E.Y.S., Wahner H.N., Muhs J.M., Cedel S.L., Melton L.J. III: Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N. Engl. J. Med. 322: 802\u2013809, 1990.","journal-title":"N. Engl. J. Med."},{"key":"BF03339660_CR23","unstructured":"Kleerekoper M., Peterson E.L., Nelson D.A., Phillips E., Schork M.A., Tilley B.C., Parfitt A.M.: A randomized trial of"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03339660.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03339660\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03339660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T06:23:21Z","timestamp":1558506201000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03339660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["BF03339660"],"URL":"https:\/\/doi.org\/10.1007\/bf03339660","relation":{},"ISSN":["1594-0667","1720-8319"],"issn-type":[{"value":"1594-0667","type":"print"},{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}